🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this randomized controlled trial is to investigate the non-i...
Status
Recruiting
Location
Hospital Clínico Universitario de Valencia
Start Date
2026-07-08
Trial ID
NCT07583056
Treatments Being Tested
This study will be conducted to evaluate the efficacy of lecanemab in parti...
Status
Active Not Recruiting
Location
Banner Alzheimer's Institute- Clinical Trials Department
Start Date
2019-03-27
Trial ID
NCT03887455
Treatments Being Tested
The purpose of the study is to learn about the safety of MK-2225, including...
Status
Completed
Location
Clinical Pharmacology of Miami (Site 0002)
Start Date
2023-11-21
Trial ID
NCT06643390
The purpose of this study is to evaluate the safety and efficacy of Nephoxi...
Status
Unknown
Location
Jesus Hospital
Start Date
2023-12-21
Trial ID
NCT06206135
Treatments Being Tested
1. To investigate the relative bioavailability (BA) of improved tablet form...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT02259868
Treatments Being Tested
The purpose of this placebo-controlled, double-blind study is to assess the...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02608697
Treatments Being Tested
This is a randomized study of the safety and tolerability of multiple doses...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT01011959
Treatments Being Tested
The primary objective of the study is to assess pharmacokinetics, dynamics,...
Status
Completed
Location
Leeds Clinic
Start Date
2018-02-07
Trial ID
NCT03427710
The purpose of this study is to assess the efficacy and safety of ME3183 ad...
Status
Completed
Location
Northwest Arkansas Clinical Trials Center
Start Date
2022-03-24
Trial ID
NCT05268016
This is a Phase I/II clinical study to determine the maximum tolerated dose...
Status
Terminated
Location
Research Site
Start Date
2017-07-31
Trial ID
NCT03217838
Treatments Being Tested